Norris Perne & French LLP Novartis Ag Transaction History
Norris Perne & French LLP
- $1.3 Billion
- Q2 2024
A detailed history of Norris Perne & French LLP transactions in Novartis Ag stock. As of the latest transaction made, Norris Perne & French LLP holds 2,432 shares of NVS stock, worth $261,926. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,432
Previous 2,797
13.05%
Holding current value
$261,926
Previous $270,000
4.44%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,368Shares Held
141MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.33 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$782 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$648 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$637 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...